[Intralymphatic drug therapy--a pathogenetically substantiated method of treatment in peritonitis].
The method of endolymphatic drug therapy (EDT) suggested by the authors has some advantages over the method of endoarterial therapy (which has proved to be effective in clinical practice) because it is aimed not only at control of the microbial flora, but also at correction of rheologic and microcirculatory disorders, improvement of the processes of tissue respiration and metabolism, stimulation of the intestine, prevention of the damaging effect of enzymes, toxins, and poisons on the organs and tissues of the body, and at correction of disorders of the immune status with promotion of the barrier function of the lymph nodes and the lymphatic system as a whole. EDT may be recommended for wide use in the clinic in the treatment of patients with peritonitis and other serious surgical infections unresponsive to the generally applied methods of management.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D007611:Aprotinin / Q000008:administration & dosage; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D007272:Injections, Intralymphatic; D009388:Neostigmine / Q000008:administration & dosage; D010431:Pentoxifylline / Q000008:administration & dosage; D010455:Peptides / Q000008:administration & dosage*; D010538:Peritonitis / Q000188:drug therapy*; D011205:Povidone / Q000008:administration & dosage; D013949:Thymus Extracts / Q000008:administration & dosage*
D000276:Adjuvants, Immunologic; D000900:Anti-Bacterial Agents; D010455:Peptides; D013949:Thymus Extracts; D009388:Neostigmine; C007918:hemodes; C036191:T-activin; D006493:Heparin; D007611:Aprotinin; D011205:Povidone; D010431:Pentoxifylline
Endolimfaticheskaia medikamentoznaia terapiia - patogenicheski obosnovannyĭ metod lecheniia peritonita.